fate therapeutics inc
(FATE:Consolidated Issue listed on NASDAQ Global Market)
Rudolf Jaenisch M.D.
Member of Scientific & Clinical Advisory Board, OncoMed Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 46 board members in 4 different organizations across 5 different industries.|
See Board Relationships
Prof. Dr. Rudolf Jaenisch, MD, has been Scientific Advisor at TaconicArtemis GmbH since May 1999. Dr. Jaenisch is a Pioneer in Making Transgenic Mice, leading to some important advances in understanding Cancer, Neurological and Connective Tissue Diseases and Developmental Abnormalities. He served as Head of the Department of Tumor Virology at the Heinrich Pette Institute for Experimental Virology and Immunology. In 2005, he established the Human Stem Cell Facility at ...
3535 General Atomics CourtPhone: 858-875-1800
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|